ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use.
about
Current perspectives in NSAID-induced gastropathyPolypharmacy patterns: unravelling systematic associations between prescribed medicationsSafe prescribing of non-steroidal anti-inflammatory drugs in patients with osteoarthritis--an expert consensus addressing benefits as well as gastrointestinal and cardiovascular risksHospitalization in community-dwelling persons with Alzheimer's disease: frequency and causes.The potential interaction between clopidogrel and proton pump inhibitors: a systematic review.Management for non-variceal upper gastrointestinal bleeding in elderly patients: the experience of a tertiary university hospital.Multimorbidity and polypharmacy in diabetic patients with NAFLD: Implications for disease severity and management.Influences of different proton pump inhibitors on the anti-platelet function of clopidogrel in relation to CYP2C19 genotypesACG Clinical Guideline: Management of Patients With Acute Lower Gastrointestinal Bleeding.Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term low-dose aspirin therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trialHospital physicians' influence on gastrointestinal protection during treatment with non-steroidal anti-inflammatory drugs and acetylsalicylic acid and the impact on prescribing in primary care.Variability in response to clopidogrel: how important are pharmacogenetics and drug interactions?Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term non-steroidal anti-inflammatory drug (NSAID) therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled triaPooled safety analysis of diclofenac sodium topical solution 1.5% (w/w) in the treatment of osteoarthritis in patients aged 75 years or older.Long-Term Safety of a Coordinated Delivery Tablet of Enteric-Coated Aspirin 325 mg and Immediate-Release Omeprazole 40 mg for Secondary Cardiovascular Disease Prevention in Patients at GI Risk.Reducing the risk of gastroduodenal ulcers with a fixed combination of esomeprazole and low-dose acetyl salicylic acid.Acid-NSAID/aspirin interaction in peptic ulcer disease.Individualized therapy for gastroesophageal reflux disease: potential impact of pharmacogenetic testing based on CYP2C19.Incidence and risk factors of gastrointestinal bleeding in patients on low-dose aspirin therapy after percutaneous coronary intervention in Japan.Multidisciplinary management strategies for acute non-variceal upper gastrointestinal bleeding.Management of low-dose aspirin and clopidogrel in clinical practice: a gastrointestinal perspective.Leveraging the electronic health record to improve quality and safety in rheumatology.Bleeding complication of triple therapy of rivaroxaban, prasugrel, and aspirin: a case report and general discussion.Appropriateness of Acid Suppression Therapy.Frequency of nonsteroidal anti-inflammatory drug-associated ulcers.Critical appraisal of a fixed combination of esomeprazole and low dose aspirin in risk reduction.Recent advances on the management of patients with non-variceal upper gastrointestinal bleeding.Aspirin: old drug, new uses and challenges.Stress ulcer prophylaxis in non-critically ill patients: a prospective evaluation of current practice in a general surgery department.Continuous proton pump inhibitor treatment decreases upper gastrointestinal bleeding and related death in rural area in Japan.Differences in Managing Anticoagulants and Antiplatelets for Gastrointestinal Endoscopy between East and West."It looks after me": how older patients make decisions about analgesics for osteoarthritis.ACG Institute for Clinical Research and Education: fulfilling the ACG's commitment to advance clinical gastroenterology.Re-prescribing of causative drugs in persons discharged after serious drug-induced upper gastrointestinal bleeding.Review of Proton Pump Inhibitor Overuse in the US Veteran Population.
P2860
Q26827673-E407E7A4-CCC3-4F2D-BF06-90C638DDC5BCQ28537875-7664F873-D393-4D70-800B-5DE46AB18083Q30629677-5055A33B-4E67-4DCC-A218-7A9B0FCA9B15Q33158873-BDCC4D34-5853-42C1-881C-67A5F2F1899DQ33763929-0AB4F5D0-1C87-4EAF-8A86-8F2C8DE13824Q33779757-2238B91A-7AAE-41E4-9499-1ED7DFB18AABQ33879548-CC0E7875-5CF9-44F4-8069-CDF5EF27FC7BQ34174915-0E5206A4-1599-4BF9-9651-372F3E7BB58DQ34675946-314F88C0-2EAE-40F6-9EF1-13C75A542872Q35051637-A0AEBE8D-1C89-4F88-A077-8325370173A8Q35069807-4A446BE2-655E-4C3D-92E8-DF7859B89703Q35373698-EE944729-A725-42B5-80C8-035EB14D4834Q35989849-65DAFDCE-7BB7-4525-BBE3-22E75E9DAE10Q36086215-2BD61987-69C0-4D83-A132-6A4115E37C89Q37348911-AFA7F461-00E8-4C7E-AE7D-05D1897B8791Q37903846-338696B9-83B4-430D-B8E3-AEFF58928730Q37957700-18EAD31A-0FA2-4541-ADC9-A80DA2077B21Q38032920-A799688D-0F8E-4EB5-9A3B-5D92E3D566DFQ38072495-3E0673AE-C917-4456-AF5B-E3D2CB74347FQ38166285-32FB5217-D10F-4F20-BE1D-611D2EDC72DCQ38321114-2546D1E3-8AE2-49EE-B801-D09E4491E0FDQ38368489-08AA09DE-8DBB-45B5-885E-22DD565FE186Q39121292-2A8E1DA2-839C-4B46-8518-1CC6D8B8F61EQ39369057-EAE898B8-C7A5-43DF-8B50-3377FFB32196Q39611144-DDA2765B-E59C-4221-ACE1-5A26FBE3A945Q41532376-E9A8472C-00DC-4AB7-A757-2E5A78A445FCQ42406628-ED43D2A3-F162-4754-B259-E0D322BB2B88Q45013631-E3845A11-63DB-496D-8B7E-77E9D3412C73Q45733959-BD57E9A4-CD4C-48AF-9792-2BD3A0884C55Q45807693-301417CC-97B1-4D1E-A228-9209C07F95E4Q47146062-657D6D94-9558-46B8-BAC3-95DD447195A6Q48130515-223C1753-77B1-40E4-B1EE-B3CFA20EF6CFQ50659671-7AFD4ACE-2EDF-48FC-B62E-01E7F4980FEAQ53668820-D218FFA7-5177-4574-920B-0F1E42734450Q55230586-DC8493A9-7844-44D8-BF1E-4B121F203FDF
P2860
ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
ACCF/ACG/AHA 2008 expert conse ...... latelet therapy and NSAID use.
@en
ACCF/ACG/AHA 2008 expert conse ...... latelet therapy and NSAID use.
@nl
type
label
ACCF/ACG/AHA 2008 expert conse ...... latelet therapy and NSAID use.
@en
ACCF/ACG/AHA 2008 expert conse ...... latelet therapy and NSAID use.
@nl
prefLabel
ACCF/ACG/AHA 2008 expert conse ...... latelet therapy and NSAID use.
@en
ACCF/ACG/AHA 2008 expert conse ...... latelet therapy and NSAID use.
@nl
P2093
P2860
P50
P1476
ACCF/ACG/AHA 2008 expert conse ...... latelet therapy and NSAID use.
@en
P2093
American College of Gastroenterology
Charles R Bridges
Curt D Furberg
David A Johnson
Deborah J Wesley
Deepak L Bhatt
Eamonn M Quigley
Eric R Bates
Francis K L Chan
Howard H Weitz
P2860
P304
P356
10.1111/J.1572-0241.2008.02216.X
P407
P50
P577
2008-10-03T00:00:00Z